Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell, Circulating Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04771871
What this trial is testing

MicroRNA Profiles in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
University College Hospital, Ibadan 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04604067
What this trial is testing

Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.

Who this might be right for
Diffuse Large B-cell Lymphoma
Swiss Cancer Institute 260
Not applicableLooking for participantsNCT06167460
What this trial is testing

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Who this might be right for
Non Small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer+2 more
Gene Solutions 50
Not applicableActive Not RecruitingNCT05091190
What this trial is testing

Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers

Who this might be right for
Metastatic NSCLCMetastatic Head and Neck Cancer
Hospices Civils de Lyon 75
Not applicableUnknownNCT05536843
What this trial is testing

Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests

Who this might be right for
Cervical Dysplasia, UterineVaginal DysplasiaVulvar Dysplasia
University of Mississippi Medical Center 500
Not applicableStudy completedNCT03562819
What this trial is testing

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
AstraZeneca 268
Not applicableUnknownNCT04932343
What this trial is testing

Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Samsung Medical Center 20
Not applicableLooking for participantsNCT06154668
What this trial is testing

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

Who this might be right for
Melanoma
University Hospital, Grenoble 707
Not applicableStudy completedNCT00898391
What this trial is testing

Study of DNA in Blood Samples From Patients With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 329
Not applicableLooking for participantsNCT07516678
What this trial is testing

Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-sen University 200
Not applicableLooking for participantsNCT06561178
What this trial is testing

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Not applicableUnknownNCT05486988
What this trial is testing

CtDNA as a Biomarker for Treatment in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Fuzhou General Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT06067503
What this trial is testing

Biomarkers to Detect Endocrine Therapy Resistance

Who this might be right for
Metastatic CancerBreast CancerLobular Breast Carcinoma
University of Wisconsin, Madison 8
Not applicableActive Not RecruitingNCT05662345
What this trial is testing

ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Menarini Silicon Biosystems, INC 65
Not applicableStudy completedNCT04763148
What this trial is testing

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Herlev Hospital 26
Testing effectiveness (Phase 2)Study completedNCT03077243
What this trial is testing

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 195
Not applicableLooking for participantsNCT05502523
What this trial is testing

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
Thomas Jefferson University 100
Not applicableLooking for participantsNCT07756437
What this trial is testing

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Upper Tract Urothelial CarcinomaUrothelial Carcinoma (UC)
AZ Sint-Lucas Gent 70
Not applicableStudy completedNCT03267381
What this trial is testing

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 37
Not applicableWithdrawnNCT04580667
What this trial is testing

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

Who this might be right for
Prostate Cancer
DiaCarta, Inc.
Next Page